Acta Pharmaceutica Sinica B

96.2k citations
2.3k papers · indexed · active since 1950
Topics
Nanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery

In The Last Decade

Acta Pharmaceutica Sinica B

2.2k papers receiving 94.7k citations

Peers

Acta Pharmaceutica Sinica B
Comparison fields: 5 of 210
  • Molecular Biology 43.4k
  • Biomedical Engineering 15.0k
  • Oncology 12.0k
  • Biomaterials 10.3k
  • Immunology 10.2k
Replace Drug Design Development and Therapy with:
Drug Design Development and Therapy China
Toxicology in Vitro United States
Archives of Pharmacal Research South Korea
The AAPS Journal United States
Current Topics in Medicinal Chemistry United States
Drug Discovery Today United States
Journal of Photochemistry and Photobiology B Biology China
Journal of Nanobiotechnology China
Acta Pharmacologica Sinica China
ChemMedChem United States
Acta Pharmaceutica Sinica B relative to Drug Design Development and Therapy China Drug Design Development and Therapy's profile →
Citations per field
00.5×3.1×
Drug Design Development and Therapy · 1×
Citations per year

Countries where authors publish in Acta Pharmaceutica Sinica B

Since Specialization
Citations

This map shows the geographic impact of research published in Acta Pharmaceutica Sinica B. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Acta Pharmaceutica Sinica B with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Acta Pharmaceutica Sinica B more than expected).

Fields of papers published in Acta Pharmaceutica Sinica B

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Acta Pharmaceutica Sinica B. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Acta Pharmaceutica Sinica B.

About Acta Pharmaceutica Sinica B

The 2.3k papers published in Acta Pharmaceutica Sinica B in the last decades have received a total of 96.2k indexed citations . Papers published in Acta Pharmaceutica Sinica B usually cover Pharmaceutical Science (130 papers), Pharmacology (163 papers) and Molecular Biology (1.2k papers) specifically the topics of Nanoplatforms for cancer theranostics (255 papers), Nanoparticle-Based Drug Delivery (156 papers) and RNA Interference and Gene Delivery (141 papers). The most active scholars publishing in Acta Pharmaceutica Sinica B are Wěi Li, Xiangming Guan, Huile Gao, Vijaykumar Nekkanti, Zongru Guo, Venkatareddy Nadithe, Ningning Yang, Liwu Fu, Wei Wu and Yi Lü.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2026